Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Strategic shift prioritizes the development of GLP-1 implants for the treatment of obesity and chronic weight management Positive NPM-115 preclinical weight loss data comparable to semaglutide,...